Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRAMOMTANA multidisciplinary treatment for morbid obesity
2009-013737-24Phase 4Active
- Sponsor
- Hospital Universitari Son Dureta
- Start
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of sibutramine in class III obesity (3 arms), sponsored by Hospital Universitari Son Dureta. Primary endpoints: Body weight change and Waist circumference change. Started Sep 2009; status: active.
02
Drugs
sibutramine
03
Conditions
class III obesity
Beyond the preview
Go deeper on 2009-013737-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013737-24.